X
Back to list

Welcome back, MedscapeLIVE! Dermatology readers! Pigmentary Disorders Exchange (PDE) Symposium is in two weeks. Will you be going? You can view the meeting info and Agenda here, and Register here!

Drs. Nada Elbuluk and Seaver Soon, who serve as PDE faculty, share some clutch responses to my rapid-fire questions on everything from dermatology’s most critical new advance to their most reliable dermatology treatment. Big shout out to these doctors for sharing gut reactions on some fun topics. Scroll down to read!

Don’t miss this month’s Derm Resource section—which includes articles from JAMA Dermatology on Isotretinoin Treatment in Adolescence and Adult Height, Dermatology News on Biosimilars in Dermatology, Cutis on Alignment of ChatGPT Responses With AAD Guidelines for Cutaneous Melanoma, NEJM on a Phase 3 Trial of Brepocitinib in Dermatomyositis and a Medscape Medical Intelligence Quiz on Risk Factors for Actinic Keratoses.

Thank you again to Dr. Seaver Soon and Dr. Nada Elbuluk for sharing their time and experienced perspectives. Please contact me at colleen@cmhadvisors.com with comments or suggestions, and thanks for reading!—Colleen Hutchinson

Rapid Fire with Our PDE Faculty

Most critical new advance in my area of dermatology treatment:

Dr. Nada Elbuluk: Future use of oral JAK inhibitors for vitiligo once FDA-approved.

Dr. Seaver Soon: Deep chemical peeling for pigmentation.

Issue in dermatology that needs more attention to solutions:

Dr. Elbuluk: Better treatment options and research of ADMH disorders.

Dr. Soon: Role of the skin microbiome in skin health and disease.

What I’d like to see to address the above-mentioned issue:

Dr. Elbuluk: Clinical trials for ADMH conditions.

Dr. Seaver Soon: Better ecosystem characterization.

Why PDE is a critical meeting for today’s dermatologist:

Dr. Elbuluk: Pigmentary disorders are amongst the most common conditions domestically and globally, which underscores the importance of staying up to date with diagnosis and treatment options.

Dr. Seaver Soon: Cutting edge knowledge and networking opportunity with experts in a beautiful space.

Looking forward to hearing discussion of this topic at PDE:

Dr. Elbuluk: New treatment options including combination therapy approaches.

Dr. Seaver Soon: Updates in melasma.

Most reliable dermatology treatment in my treatment armamentarium: Dr. Elbuluk: Retinoids.

Dr. Seaver Soon: Superficial peels for pigmentation.

Something not ready for prime time but will be a critical weapon to add to the arsenal if/when approved:

Dr. Elbuluk: Future use of oral JAK inhibitors for vitiligo once FDA-approved.

Dr. Seaver Soon: Deep chemical peels for melasma.

My mentor:

Dr. Elbuluk: So many, including several PDES speakers- Dr. Pearl Grimes, Dr. Susan Taylor, Dr. Sewon Kang, Dr. Amit Pandya, and Dr. Bill James.

Dr. Seaver Soon: Harold J. Brody, MD.

Best part about my job:

Dr. Elbuluk: My patients and helping treat their conditions and improve their quality of life.

Dr. Seaver Soon: The special connection that attends long-term patient relationships.

Med school class I’d love to take again:

Dr. Elbuluk: Anatomy.

Dr. Seaver Soon: Microbiology.

Need CME in 2026? Head to New York, Las Vegas, Chicago….or even stay home!

We’ve got you covered with these 2026 CME conference opportunities. Register now using the links provided and get those CME requirements off your plate:

Pigmentary Disorders Exchange (PDE) Symposium 2026

June 6-7, 2026 | Loews Chicago Hotel in Chicago, IL

For more info, click here!

COMPLIMENTARY: Virtual Hair & Scalp Disorders: The Rx Pad and Beyond

June 20, 2026

Online!

For more info, click here!

Las Vegas Derm (27th Annual!)

September 17-19, 2026

Bellagio Hotel Las Vegas, Las Vegas, NV

For more info, click here!

Skin of Color Update (SOCU)

October 9-11, 2026 | New York Hilton Midtown, New York, NY

For more info, click here!

Dermatology Resource Section

Medscape Medical News—From Maui Derm Hawaii: Biologic Plus GLP-1 Agonist Improves Quality of Life in Psoriatic Disease

JAMA Dermatology Original Investigation— Isotretinoin Treatment in Adolescence and Adult Height

Cutis Original Investigation— Alignment of ChatGPT Responses With AAD Guidelines for Cutaneous Melanoma

NEJM Editorial: A Phase 3 Trial of Brepocitinib in Dermatomyositis

Medscape Medical News: The Bare Minimum You Need to Do to Add a Year to Your Life

Dermatology News MedBrief: What About Biosimilars in Dermatology? Q&A With Steven R. Feldman, MD, PhD

JAMA Dermatology Editorial— Targeting Cardiometabolic Disease to Improve Psoriasis—A New Treatment Paradigm Emerges

Medscape MedBrief: Many Asymptomatic Patients Seeking Skin Cancer Surveillance Are Often Low Risk

MEDSCAPE MD-IQ QUIZ: Risk factors for actinic keratoses

Disclaimer: Entering your email address automatically subscribes you to future email communications from MedscapeLIVE events.